Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    Know your customer: Strategic considerations for AI-powered provider segmentation
    1 October 2024

    Know your customer: strategic considerations for AI-powered provider segmentation

    Published in Life Science Leader, CRA’s Robert Broadnax, Eddie Li and Brian Carpenter co-authored an article “Know Your Customer: Strategic Considerations for AI-Powered Provider Segmentation,” focused on the strategic considerations for drug manufacturers in developing an AI-powered pr...

    Owlstone medical logo
    30 September 2024

    Owlstone Medical partners with the FDA to advance the identification of volatile organic compounds in breath and expand its Breath Biopsy VOC Atlas.

    Collaboration will develop analytical methods to improve the identification of specific chemicals in complex gaseous mixtures Owlstone will use the developed methods and techniques to enhance its work in the field of breath-based biomarkers of disease Project will also help extend ...

    Fujifilm logo
    27 September 2024

    FUJIFILM Irvine Scientific Adds Key Products To Its Life Sciences Portfolio From FUJIFILM Wako Chemicals U.S.A.

    Additional products in lab automation, lab chemicals and LAL expand complete solutions available directly from FUJIFILM Irvine Scientific to customers in US and Europe Sales agreement aligns business and commercial operations to maximize customer benefit SANTA ANA, Calif: FUJIFILM...

    transforming healthcare
    26 September 2024

    Transforming healthcare: the power of purpose-led partnerships

    In this episode, ⁠Dr Bipin Patel⁠ sits down with ⁠Samuel Hollis⁠, Country President and Managing Director at ⁠Novartis⁠ to explore the key elements of forming impactful healthcare partnerships. ...

    Dr John Ford, CEO, Enterprise Therapeutics
    26 September 2024

    Enterprise Therapeutics granted ‘rare pediatric disease designation’ in the US for novel cystic fibrosis investigational therapy ETD001

    ETD001 is a novel, first in class blocker of the epithelial sodium channel (ENaC) aimed at treating people with cystic fibrosis without current effective therapies ETD001 commenced Phase 2 clinical trials in July 2024, expected to complete in 2025 Brighton, UK: Enterprise Therapeu...

    Dengue fever
    25 September 2024

    Takeda’s Qdenga® - more campaigns needed before single-dose products arrive

    This month VacZine Analytics, a specialist in infectious diseases and vaccines commercial analysis publishes a brand-new global analysis of the dengue endemic vaccines market. ...

    logo
    24 September 2024

    Steritas’ Pediatric Glucocorticoid Toxicity Index used by Alder Hey and Liverpool Trials Centre to assess steroid toxicity in children with juvenile idiopathic arthritis

    Study will allow researchers to assess the outcomes of intravenous and oral glucocorticoid protocols in children ...

     Laurence Reid, PhD, Chair of the Board	 Brad Crutchfield, Non-Executive Director	 Felix Dobbs, PhD, CEO
    23 September 2024

    Broken String Biosciences appoints Laurence Reid and Brad Crutchfield to its Board of Directors

    Laurence Reid joins as Chairman, previously Decibel Therapeutics, Warp Drive Bio, Alnylam, and Third Rock Ventures Brad Crutchfield appointed as Non-Executive Director, previously 10x Genomics, QIAGEN, Illumina, and Bio-Rad Laboratories Cambridge, UK, 23 September 2024: Broken Str...

    Teaching-The-Next-Generation-Of-Innovators-Andy-Milton-Innovia-Technology
    20 September 2024

    Teaching the next generation of innovators...

    Why does the planet need entrepreneurship? What can the next generation of innovators learn from big businesses? ...

    Decon Team
    23 September 2024

    Give your cleanroom the TLC it needs with Guardtech’s first-class decontamination programmes and elite furniture fit-outs

    The Guardtech Group are urging clients to ensure their controlled environments are free of contamination and fully equipped to deliver the best results ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 126
    • Page 127
    • Current page 128
    • Page 129
    • Page 130
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS